Healthpeak Properties’ (DOC) “Buy” Rating Reiterated at Mizuho

Healthpeak Properties (NYSE:DOC)‘s stock had its “buy” rating reiterated by equities research analysts at Mizuho in a report issued on Monday, Marketbeat Ratings reports. They presently have a $22.00 price target on the real estate investment trust’s stock. Mizuho’s target price points to a potential upside of 19.24% from the company’s current price.

A number of other research analysts also recently issued reports on the company. Compass Point reduced their price target on Healthpeak Properties from $19.00 to $18.00 and set a “buy” rating on the stock in a report on Tuesday, January 2nd. Wells Fargo & Company began coverage on Healthpeak Properties in a report on Monday, March 25th. They set an “equal weight” rating and a $19.00 target price for the company. KeyCorp reissued a “sector weight” rating on shares of Healthpeak Properties in a research report on Friday, January 5th. StockNews.com raised shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a research report on Friday, April 5th. Finally, Bank of America raised shares of Healthpeak Properties from an “underperform” rating to a “buy” rating and lifted their price target for the company from $18.00 to $25.00 in a research report on Monday, April 1st. Six research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, Healthpeak Properties presently has a consensus rating of “Hold” and an average target price of $18.10.

Healthpeak Properties Price Performance

Shares of Healthpeak Properties stock opened at $18.45 on Monday. The firm has a market cap of $13.09 billion, a PE ratio of 32.95, a price-to-earnings-growth ratio of 1.77 and a beta of 1.02. The company’s fifty day simple moving average is $16.24 and its two-hundred day simple moving average is $13.62. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 1.00. Healthpeak Properties has a 12-month low of $15.24 and a 12-month high of $22.38.

Institutional Investors Weigh In On Healthpeak Properties

Several institutional investors and hedge funds have recently made changes to their positions in the company. Parallel Advisors LLC boosted its stake in Healthpeak Properties by 274.6% during the 4th quarter. Parallel Advisors LLC now owns 4,072 shares of the real estate investment trust’s stock valued at $54,000 after purchasing an additional 2,985 shares during the last quarter. Allspring Global Investments Holdings LLC increased its holdings in Healthpeak Properties by 42.4% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 5,750 shares of the real estate investment trust’s stock worth $70,000 after buying an additional 1,712 shares in the last quarter. Quadrant Capital Group LLC raised its position in Healthpeak Properties by 645.4% in the 4th quarter. Quadrant Capital Group LLC now owns 9,646 shares of the real estate investment trust’s stock worth $128,000 after buying an additional 8,352 shares during the last quarter. Stratos Wealth Partners LTD. bought a new position in Healthpeak Properties during the 4th quarter valued at about $134,000. Finally, Envestnet Portfolio Solutions Inc. purchased a new stake in shares of Healthpeak Properties during the 3rd quarter valued at about $124,000. Institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.